Loading...

Fund Overview

Fund Size

Fund Size

₹1,634 Cr

Expense Ratio

Expense Ratio

2.10%

ISIN

ISIN

INF179KC1HL7

Minimum SIP

Minimum SIP

₹100

Exit Load

Exit Load

1.00%

Inception Date

Inception Date

04 Oct 2023

About this fund

HDFC Pharma and Healthcare Fund Regular Growth is a Sector - Healthcare mutual fund schemes offered by HDFC Mutual Fund. This fund has been in existence for 1 years, 6 months and 15 days, having been launched on 04-Oct-23.
As of 17-Apr-25, it has a Net Asset Value (NAV) of ₹15.78, Assets Under Management (AUM) of 1634.08 Crores, and an expense ratio of 2.1%.
  • HDFC Pharma and Healthcare Fund Regular Growth has given a CAGR return of 34.86% since inception.
  • The fund's asset allocation comprises around 95.66% in equities, 0.00% in debts, and 2.72% in cash & cash equivalents.
  • You can start investing in HDFC Pharma and Healthcare Fund Regular Growth with a SIP of ₹100 or a Lumpsum investment of ₹100.

Performance against Category Average

In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.

1 Year

+27.74%

+17.55% (Cat Avg.)

Since Inception

+34.86%

(Cat Avg.)

Portfolio Summaryas of 31st March 2025

Equity1,563.2 Cr95.66%
Others44.5 Cr2.72%

Top Holdings

All Holdings

Equity

Debt & Others

NameType sortAmount sortHoldings sort
Sun Pharmaceuticals Industries LtdEquity193.4 Cr11.84%
Divi's Laboratories LtdEquity139.71 Cr8.55%
Cipla LtdEquity117.44 Cr7.19%
Lupin LtdEquity88.67 Cr5.43%
Max Healthcare Institute Ltd Ordinary SharesEquity80.22 Cr4.91%
Krishna Institute of Medical Sciences LtdEquity66.05 Cr4.04%
Glenmark Pharmaceuticals LtdEquity60.68 Cr3.71%
Torrent Pharmaceuticals LtdEquity59.26 Cr3.63%
Aster DM Healthcare Ltd Ordinary SharesEquity57.78 Cr3.54%
Eris Lifesciences Ltd Registered ShsEquity54.1 Cr3.31%
Aurobindo Pharma LtdEquity53.76 Cr3.29%
Ipca Laboratories LtdEquity53.26 Cr3.26%
Treps - Tri-Party RepoCash - Repurchase Agreement49.83 Cr3.05%
Wockhardt LtdEquity48.9 Cr2.99%
Vijaya Diagnostic Centre LtdEquity42.97 Cr2.63%
Alkem Laboratories LtdEquity41.35 Cr2.53%
Gland Pharma LtdEquity41.24 Cr2.52%
Piramal Pharma LtdEquity39.44 Cr2.41%
Metropolis Healthcare LtdEquity36.89 Cr2.26%
Ami Organics LtdEquity32.73 Cr2.00%
Global Health LtdEquity30.27 Cr1.85%
Fortis Healthcare LtdEquity29.28 Cr1.79%
Laxmi Dental LtdEquity28.69 Cr1.76%
Bajaj Healthcare Limited - Prefential IssuePreferred Stock26.37 Cr1.61%
Suven Pharmaceuticals LtdEquity25.1 Cr1.54%
Jubilant Pharmova LtdEquity21.48 Cr1.31%
Ajanta Pharma LtdEquity20.34 Cr1.24%
Pfizer LtdEquity19.75 Cr1.21%
Dr Reddy's Laboratories LtdEquity19.63 Cr1.20%
Sai Life Sciences LtdEquity19.36 Cr1.18%
Zydus Lifesciences LtdEquity17.52 Cr1.07%
Medi Assist Healthcare Services LtdEquity16.94 Cr1.04%
Bajaj Healthcare LtdEquity6.99 Cr0.43%
Net Current AssetsCash-5.33 Cr0.33%

Allocation By Market Cap (Equity)

Large Cap Stocks

33.47%

Mid Cap Stocks

26.17%

Small Cap Stocks

34.27%

Other Allocation

Equity Sector

Debt & Others

SectorAmount sortHoldings sort
Healthcare1,530.47 Cr93.66%
Basic Materials32.73 Cr2.00%

Risk & Performance Ratios

Standard Deviation

This fund

--

Cat. avg.

16.77%

Lower the better

Sharpe Ratio

This fund

--

Cat. avg.

0.75

Higher the better

Sortino Ratio

This fund

--

Cat. avg.

1.30

Higher the better

Fund Managers

DM

Dhruv Muchhal

Since October 2023

Nikhil Mathur

Nikhil Mathur

Since October 2023

Additional Scheme Detailsas of 31st March 2025

ISIN
INF179KC1HL7
Expense Ratio
2.10%
Exit Load
1.00%
Fund Size
₹1,634 Cr
Age
1 year 6 months
Lumpsum Minimum
₹100
Fund Status
Open Ended Investment Company
Benchmark
BSE Healthcare TR INR

Investment ObjectiveInvestment Objective

To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.

Tax Treatment

iconCapital Gains Taxation:

iconDividend Taxation:

info icon

Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Similar Sector - Healthcare Funds

Fund nameExpense RatioExit LoadFund size
1Y
Bajaj Finserv Healthcare Fund Regular Growth

Very High Risk

2.4%1.0%₹307.40 Cr-
Bajaj Finserv Healthcare Fund Direct Growth

Very High Risk

0.6%1.0%₹307.40 Cr-
PGIM India Healthcare Fund Direct Growth

Very High Risk

0.7%0.0%₹104.18 Cr-
PGIM India Healthcare Fund Regular Growth

Very High Risk

2.4%0.0%₹104.18 Cr-
WhiteOak Capital Pharma and Healthcare Fund Regular Growth

Very High Risk

2.4%1.0%₹303.62 Cr26.8%
WhiteOak Capital Pharma and Healthcare Fund Direct Growth

Very High Risk

0.6%1.0%₹303.62 Cr29.0%
DSP Nifty Healthcare ETF Regular Growth

Very High Risk

0.2%-₹9.77 Cr15.8%
Kotak Healthcare Fund Direct Growth

Very High Risk

0.8%0.0%₹411.54 Cr16.3%
Kotak Healthcare Fund Regular Growth

Very High Risk

2.4%0.0%₹411.54 Cr14.4%
HDFC Pharma and Healthcare Fund Regular Growth

Very High Risk

2.1%1.0%₹1634.08 Cr27.7%

About the AMC

HDFC Mutual Fund

HDFC Mutual Fund

Total AUM

₹7,00,201 Cr

Address

“HUL House”, 2nd Floor, Mumbai, 400 020

Other Funds by HDFC Mutual Fund

Fund nameExpense RatioExit LoadFund size
1Y
HDFC Pharma and Healthcare Fund Direct Growth

Very High Risk

0.9%1.0%₹1634.08 Cr29.3%
HDFC Technology Fund Direct Growth

Very High Risk

1.0%1.0%₹1359.15 Cr12.1%
HDFC Fixed Maturity Plan 1162 Days March 2022 Series 46 Direct Growth

Low Risk

-0.0%₹32.90 Cr7.3%
HDFC FMP 1204D December 2022 (47) Direct Growth

Low to Moderate Risk

--₹51.24 Cr8.1%
HDFC Fixed Maturity Plans 1269 Days March 2023 Series 47 Direct Growth

Low to Moderate Risk

-0.0%₹76.38 Cr8.6%
HDFC Fixed Maturity Plans 1359 Days September 2022 Series 46 Direct Growth

Low to Moderate Risk

-0.0%₹316.54 Cr8.3%
HDFC Fixed Maturity Plan 1406 Days August 2022 Series 46 Direct Growth

Moderate Risk

-0.0%₹246.30 Cr8.4%
HDFC Fixed Maturity Plans 1113 Days March 2019 Series 44 Plan 1 Direct Growth

Moderate Risk

-0.0%--
HDFC Fixed Maturity Plan 1876 Days Series 46 Direct Growth

Low to Moderate Risk

-0.0%₹32.39 Cr9.3%
HDFC Fixed Maturity Plans Series 46 1158D July 2022 Direct Growth

Low Risk

-0.0%₹161.40 Cr7.6%
HDFC Fixed Maturity Plan 1861 Days Series 46 Direct Growth

Low to Moderate Risk

-0.0%₹462.77 Cr9.3%
HDFC FMP 2638D February 2023 (47) Direct Growth

Moderate Risk

-0.0%₹151.02 Cr12.3%
HDFC Fixed Maturity Plans 1127 Days April 2019 Series 44 Plan 1 Direct Growth

Moderate Risk

----
HDFC Balanced Advantage Fund Direct Growth

Very High Risk

0.8%1.0%₹94824.34 Cr9.5%
HDFC Hybrid Equity Fund Direct Growth

Very High Risk

1.1%1.0%₹23229.08 Cr10.0%
HDFC Dynamic PE Ratio Fund of Funds Plan A Direct Growth

Moderate Risk

0.2%0.0%₹69.69 Cr7.0%
HDFC Small Cap Fund Direct Growth

Very High Risk

0.8%1.0%₹30223.46 Cr1.0%
HDFC Housing Opportunities Fund Direct Growth

Very High Risk

1.3%1.0%₹1257.48 Cr1.1%
HDFC Large and Mid Cap Fund Direct Growth

Very High Risk

1.0%1.0%₹23379.95 Cr8.4%
HDFC Nifty G-Sec July 2031 Index Fund Direct Growth

Moderate Risk

0.2%0.0%₹694.70 Cr12.5%
HDFC Nifty G-sec Dec 2026 Index Fund Direct Growth

Low to Moderate Risk

0.2%0.0%₹1324.80 Cr8.6%
HDFC Business Cycle Fund Direct Growth

Very High Risk

0.9%1.0%₹2762.36 Cr6.2%
HDFC NIFTY Smallcap 250 Index Fund Direct Growth

Very High Risk

0.3%0.0%₹400.43 Cr1.6%
HDFC Credit Risk Debt Fund Direct Growth

High Risk

1.0%1.0%₹7229.73 Cr9.4%
HDFC Nifty SDL Oct 2026 Index Fund Direct Growth

Low to Moderate Risk

0.2%0.0%₹199.12 Cr8.6%
HDFC Banking and PSU Debt Fund Direct Growth

Moderate Risk

0.4%0.0%₹5995.94 Cr9.7%
HDFC Banking & Financial Services Fund Direct Growth

Very High Risk

1.0%1.0%₹3722.44 Cr16.6%
HDFC Non-Cyclical Consumer Fund Direct Growth

Very High Risk

1.1%1.0%₹901.19 Cr11.9%
HDFC Asset Allocator Fund of Funds Direct Growth

High Risk

0.1%1.0%₹3683.29 Cr13.5%
HDFC Gold Fund Direct Growth

High Risk

0.2%1.0%₹3557.61 Cr28.3%
HDFC Gilt Fund Direct Growth

Moderate Risk

0.5%0.0%₹2907.41 Cr12.0%
HDFC Dynamic Debt Fund Direct Growth

Moderate Risk

0.8%0.0%₹778.49 Cr11.3%
HDFC Medium Term Debt Fund Direct Growth

Moderately High risk

0.7%0.0%₹3860.84 Cr10.2%
HDFC Income Fund Direct Growth

Moderate Risk

0.8%0.0%₹884.76 Cr11.4%
HDFC Infrastructure Fund Direct Growth

Very High Risk

1.0%1.0%₹2329.22 Cr6.0%
HDFC Liquid Fund Direct Growth

Low to Moderate Risk

0.2%0.0%₹50517.49 Cr7.4%
HDFC Corporate Bond Fund Direct Growth

Low to Moderate Risk

0.4%0.0%₹32526.64 Cr10.0%
HDFC Mid-Cap Opportunities Fund Direct Growth

Very High Risk

0.8%1.0%₹72610.08 Cr10.0%
HDFC Hybrid Debt Fund Direct Growth

Moderately High risk

1.1%1.0%₹3309.97 Cr10.0%
HDFC TaxSaver Direct Growth

Very High Risk

1.1%0.0%₹15555.71 Cr15.7%
HDFC Multi - Asset Fund Direct Growth

Very High Risk

0.8%1.0%₹3837.22 Cr12.0%
HDFC Equity Savings Fund Direct Growth

Moderately High risk

0.9%1.0%₹5460.36 Cr7.8%
HDFC Short Term Debt Fund Direct Growth

Low to Moderate Risk

0.4%0.0%₹14207.90 Cr9.7%
HDFC Top 100 Fund Direct Growth

Very High Risk

1.0%1.0%₹36108.73 Cr7.7%
HDFC S&P BSE 500 Index Fund Direct Growth

Very High Risk

0.3%0.0%₹208.37 Cr6.1%
HDFC Nifty Midcap 150 Index Fund Direct Growth

Very High Risk

0.3%0.0%₹291.20 Cr6.4%
HDFC Dividend Yield Fund Direct Growth

Very High Risk

0.8%1.0%₹5963.69 Cr5.2%
HDFC Low Duration Fund Direct Growth

Moderate Risk

0.5%0.0%₹18185.04 Cr8.4%
HDFC Arbitrage Fund Direct Growth

Low Risk

0.4%0.0%₹18350.43 Cr7.9%
HDFC Capital Builder Value Fund Direct Growth

Very High Risk

1.1%1.0%₹6806.23 Cr11.4%

Risk Level

Your principal amount will be at Very High Risk

Very High Risk

Take control of your wealth

Track and Analyse all your investments with Wealth Monitor

qr

Rated ★ 4.3+ on

playstoreappstore

Still got questions?
We're here to help.

The NAV of HDFC Pharma and Healthcare Fund Regular Growth, as of 17-Apr-2025, is ₹15.78.
The fund's allocation of assets is distributed as 95.66% in equities, 0.00% in bonds, and 2.72% in cash and cash equivalents.
The fund managers responsible for HDFC Pharma and Healthcare Fund Regular Growth are:-
  1. Dhruv Muchhal
  2. Nikhil Mathur

Fund Overview

Fund Size

Fund Size

₹1,634 Cr

Expense Ratio

Expense Ratio

2.10%

ISIN

ISIN

INF179KC1HL7

Minimum SIP

Minimum SIP

₹100

Exit Load

Exit Load

1.00%

Inception Date

Inception Date

04 Oct 2023

Risk Level

Your principal amount will be at Very High Risk

Very High Risk

About this fund

HDFC Pharma and Healthcare Fund Regular Growth is a Sector - Healthcare mutual fund schemes offered by HDFC Mutual Fund. This fund has been in existence for 1 years, 6 months and 15 days, having been launched on 04-Oct-23.
As of 17-Apr-25, it has a Net Asset Value (NAV) of ₹15.78, Assets Under Management (AUM) of 1634.08 Crores, and an expense ratio of 2.1%.
  • HDFC Pharma and Healthcare Fund Regular Growth has given a CAGR return of 34.86% since inception.
  • The fund's asset allocation comprises around 95.66% in equities, 0.00% in debts, and 2.72% in cash & cash equivalents.
  • You can start investing in HDFC Pharma and Healthcare Fund Regular Growth with a SIP of ₹100 or a Lumpsum investment of ₹100.

Performance against Category Average

In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.

1 Year

+27.74%

+17.55% (Cat Avg.)

Since Inception

+34.86%

(Cat Avg.)

Portfolio Summaryas of 31st March 2025

Equity1,563.2 Cr95.66%
Others44.5 Cr2.72%

Top Holdings

All Holdings

Equity

Debt & Others

NameType sortAmount sortHoldings sort
Sun Pharmaceuticals Industries LtdEquity193.4 Cr11.84%
Divi's Laboratories LtdEquity139.71 Cr8.55%
Cipla LtdEquity117.44 Cr7.19%
Lupin LtdEquity88.67 Cr5.43%
Max Healthcare Institute Ltd Ordinary SharesEquity80.22 Cr4.91%
Krishna Institute of Medical Sciences LtdEquity66.05 Cr4.04%
Glenmark Pharmaceuticals LtdEquity60.68 Cr3.71%
Torrent Pharmaceuticals LtdEquity59.26 Cr3.63%
Aster DM Healthcare Ltd Ordinary SharesEquity57.78 Cr3.54%
Eris Lifesciences Ltd Registered ShsEquity54.1 Cr3.31%
Aurobindo Pharma LtdEquity53.76 Cr3.29%
Ipca Laboratories LtdEquity53.26 Cr3.26%
Treps - Tri-Party RepoCash - Repurchase Agreement49.83 Cr3.05%
Wockhardt LtdEquity48.9 Cr2.99%
Vijaya Diagnostic Centre LtdEquity42.97 Cr2.63%
Alkem Laboratories LtdEquity41.35 Cr2.53%
Gland Pharma LtdEquity41.24 Cr2.52%
Piramal Pharma LtdEquity39.44 Cr2.41%
Metropolis Healthcare LtdEquity36.89 Cr2.26%
Ami Organics LtdEquity32.73 Cr2.00%
Global Health LtdEquity30.27 Cr1.85%
Fortis Healthcare LtdEquity29.28 Cr1.79%
Laxmi Dental LtdEquity28.69 Cr1.76%
Bajaj Healthcare Limited - Prefential IssuePreferred Stock26.37 Cr1.61%
Suven Pharmaceuticals LtdEquity25.1 Cr1.54%
Jubilant Pharmova LtdEquity21.48 Cr1.31%
Ajanta Pharma LtdEquity20.34 Cr1.24%
Pfizer LtdEquity19.75 Cr1.21%
Dr Reddy's Laboratories LtdEquity19.63 Cr1.20%
Sai Life Sciences LtdEquity19.36 Cr1.18%
Zydus Lifesciences LtdEquity17.52 Cr1.07%
Medi Assist Healthcare Services LtdEquity16.94 Cr1.04%
Bajaj Healthcare LtdEquity6.99 Cr0.43%
Net Current AssetsCash-5.33 Cr0.33%

Allocation By Market Cap (Equity)

Large Cap Stocks

33.47%

Mid Cap Stocks

26.17%

Small Cap Stocks

34.27%

Other Allocation

Equity Sector

Debt & Others

SectorAmount sortHoldings sort
Healthcare1,530.47 Cr93.66%
Basic Materials32.73 Cr2.00%

Risk & Performance Ratios

Standard Deviation

This fund

--

Cat. avg.

16.77%

Lower the better

Sharpe Ratio

This fund

--

Cat. avg.

0.75

Higher the better

Sortino Ratio

This fund

--

Cat. avg.

1.30

Higher the better

Fund Managers

DM

Dhruv Muchhal

Since October 2023

Nikhil Mathur

Nikhil Mathur

Since October 2023

Additional Scheme Detailsas of 31st March 2025

ISIN
INF179KC1HL7
Expense Ratio
2.10%
Exit Load
1.00%
Fund Size
₹1,634 Cr
Age
1 year 6 months
Lumpsum Minimum
₹100
Fund Status
Open Ended Investment Company
Benchmark
BSE Healthcare TR INR

Investment ObjectiveInvestment Objective

To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.

Tax Treatment

iconCapital Gains Taxation:

iconDividend Taxation:

info icon

Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Similar Sector - Healthcare Funds

Fund nameExpense RatioExit LoadFund size
1Y
Bajaj Finserv Healthcare Fund Regular Growth

Very High Risk

2.4%1.0%₹307.40 Cr-
Bajaj Finserv Healthcare Fund Direct Growth

Very High Risk

0.6%1.0%₹307.40 Cr-
PGIM India Healthcare Fund Direct Growth

Very High Risk

0.7%0.0%₹104.18 Cr-
PGIM India Healthcare Fund Regular Growth

Very High Risk

2.4%0.0%₹104.18 Cr-
WhiteOak Capital Pharma and Healthcare Fund Regular Growth

Very High Risk

2.4%1.0%₹303.62 Cr26.8%
WhiteOak Capital Pharma and Healthcare Fund Direct Growth

Very High Risk

0.6%1.0%₹303.62 Cr29.0%
DSP Nifty Healthcare ETF Regular Growth

Very High Risk

0.2%-₹9.77 Cr15.8%
Kotak Healthcare Fund Direct Growth

Very High Risk

0.8%0.0%₹411.54 Cr16.3%
Kotak Healthcare Fund Regular Growth

Very High Risk

2.4%0.0%₹411.54 Cr14.4%
HDFC Pharma and Healthcare Fund Regular Growth

Very High Risk

2.1%1.0%₹1634.08 Cr27.7%

About the AMC

HDFC Mutual Fund

HDFC Mutual Fund

Total AUM

₹7,00,201 Cr

Address

“HUL House”, 2nd Floor, Mumbai, 400 020

Other Funds by HDFC Mutual Fund

Fund nameExpense RatioExit LoadFund size
1Y
HDFC Pharma and Healthcare Fund Direct Growth

Very High Risk

0.9%1.0%₹1634.08 Cr29.3%
HDFC Technology Fund Direct Growth

Very High Risk

1.0%1.0%₹1359.15 Cr12.1%
HDFC Fixed Maturity Plan 1162 Days March 2022 Series 46 Direct Growth

Low Risk

-0.0%₹32.90 Cr7.3%
HDFC FMP 1204D December 2022 (47) Direct Growth

Low to Moderate Risk

--₹51.24 Cr8.1%
HDFC Fixed Maturity Plans 1269 Days March 2023 Series 47 Direct Growth

Low to Moderate Risk

-0.0%₹76.38 Cr8.6%
HDFC Fixed Maturity Plans 1359 Days September 2022 Series 46 Direct Growth

Low to Moderate Risk

-0.0%₹316.54 Cr8.3%
HDFC Fixed Maturity Plan 1406 Days August 2022 Series 46 Direct Growth

Moderate Risk

-0.0%₹246.30 Cr8.4%
HDFC Fixed Maturity Plans 1113 Days March 2019 Series 44 Plan 1 Direct Growth

Moderate Risk

-0.0%--
HDFC Fixed Maturity Plan 1876 Days Series 46 Direct Growth

Low to Moderate Risk

-0.0%₹32.39 Cr9.3%
HDFC Fixed Maturity Plans Series 46 1158D July 2022 Direct Growth

Low Risk

-0.0%₹161.40 Cr7.6%
HDFC Fixed Maturity Plan 1861 Days Series 46 Direct Growth

Low to Moderate Risk

-0.0%₹462.77 Cr9.3%
HDFC FMP 2638D February 2023 (47) Direct Growth

Moderate Risk

-0.0%₹151.02 Cr12.3%
HDFC Fixed Maturity Plans 1127 Days April 2019 Series 44 Plan 1 Direct Growth

Moderate Risk

----
HDFC Balanced Advantage Fund Direct Growth

Very High Risk

0.8%1.0%₹94824.34 Cr9.5%
HDFC Hybrid Equity Fund Direct Growth

Very High Risk

1.1%1.0%₹23229.08 Cr10.0%
HDFC Dynamic PE Ratio Fund of Funds Plan A Direct Growth

Moderate Risk

0.2%0.0%₹69.69 Cr7.0%
HDFC Small Cap Fund Direct Growth

Very High Risk

0.8%1.0%₹30223.46 Cr1.0%
HDFC Housing Opportunities Fund Direct Growth

Very High Risk

1.3%1.0%₹1257.48 Cr1.1%
HDFC Large and Mid Cap Fund Direct Growth

Very High Risk

1.0%1.0%₹23379.95 Cr8.4%
HDFC Nifty G-Sec July 2031 Index Fund Direct Growth

Moderate Risk

0.2%0.0%₹694.70 Cr12.5%
HDFC Nifty G-sec Dec 2026 Index Fund Direct Growth

Low to Moderate Risk

0.2%0.0%₹1324.80 Cr8.6%
HDFC Business Cycle Fund Direct Growth

Very High Risk

0.9%1.0%₹2762.36 Cr6.2%
HDFC NIFTY Smallcap 250 Index Fund Direct Growth

Very High Risk

0.3%0.0%₹400.43 Cr1.6%
HDFC Credit Risk Debt Fund Direct Growth

High Risk

1.0%1.0%₹7229.73 Cr9.4%
HDFC Nifty SDL Oct 2026 Index Fund Direct Growth

Low to Moderate Risk

0.2%0.0%₹199.12 Cr8.6%
HDFC Banking and PSU Debt Fund Direct Growth

Moderate Risk

0.4%0.0%₹5995.94 Cr9.7%
HDFC Banking & Financial Services Fund Direct Growth

Very High Risk

1.0%1.0%₹3722.44 Cr16.6%
HDFC Non-Cyclical Consumer Fund Direct Growth

Very High Risk

1.1%1.0%₹901.19 Cr11.9%
HDFC Asset Allocator Fund of Funds Direct Growth

High Risk

0.1%1.0%₹3683.29 Cr13.5%
HDFC Gold Fund Direct Growth

High Risk

0.2%1.0%₹3557.61 Cr28.3%
HDFC Gilt Fund Direct Growth

Moderate Risk

0.5%0.0%₹2907.41 Cr12.0%
HDFC Dynamic Debt Fund Direct Growth

Moderate Risk

0.8%0.0%₹778.49 Cr11.3%
HDFC Medium Term Debt Fund Direct Growth

Moderately High risk

0.7%0.0%₹3860.84 Cr10.2%
HDFC Income Fund Direct Growth

Moderate Risk

0.8%0.0%₹884.76 Cr11.4%
HDFC Infrastructure Fund Direct Growth

Very High Risk

1.0%1.0%₹2329.22 Cr6.0%
HDFC Liquid Fund Direct Growth

Low to Moderate Risk

0.2%0.0%₹50517.49 Cr7.4%
HDFC Corporate Bond Fund Direct Growth

Low to Moderate Risk

0.4%0.0%₹32526.64 Cr10.0%
HDFC Mid-Cap Opportunities Fund Direct Growth

Very High Risk

0.8%1.0%₹72610.08 Cr10.0%
HDFC Hybrid Debt Fund Direct Growth

Moderately High risk

1.1%1.0%₹3309.97 Cr10.0%
HDFC TaxSaver Direct Growth

Very High Risk

1.1%0.0%₹15555.71 Cr15.7%
HDFC Multi - Asset Fund Direct Growth

Very High Risk

0.8%1.0%₹3837.22 Cr12.0%
HDFC Equity Savings Fund Direct Growth

Moderately High risk

0.9%1.0%₹5460.36 Cr7.8%
HDFC Short Term Debt Fund Direct Growth

Low to Moderate Risk

0.4%0.0%₹14207.90 Cr9.7%
HDFC Top 100 Fund Direct Growth

Very High Risk

1.0%1.0%₹36108.73 Cr7.7%
HDFC S&P BSE 500 Index Fund Direct Growth

Very High Risk

0.3%0.0%₹208.37 Cr6.1%
HDFC Nifty Midcap 150 Index Fund Direct Growth

Very High Risk

0.3%0.0%₹291.20 Cr6.4%
HDFC Dividend Yield Fund Direct Growth

Very High Risk

0.8%1.0%₹5963.69 Cr5.2%
HDFC Low Duration Fund Direct Growth

Moderate Risk

0.5%0.0%₹18185.04 Cr8.4%
HDFC Arbitrage Fund Direct Growth

Low Risk

0.4%0.0%₹18350.43 Cr7.9%
HDFC Capital Builder Value Fund Direct Growth

Very High Risk

1.1%1.0%₹6806.23 Cr11.4%

Still got questions?
We're here to help.

The NAV of HDFC Pharma and Healthcare Fund Regular Growth, as of 17-Apr-2025, is ₹15.78.
The fund's allocation of assets is distributed as 95.66% in equities, 0.00% in bonds, and 2.72% in cash and cash equivalents.
The fund managers responsible for HDFC Pharma and Healthcare Fund Regular Growth are:-
  1. Dhruv Muchhal
  2. Nikhil Mathur
close

Get your portfolio reviewed by experts

qr

Track all your investments in one place

Download Wealth Monitor App

cross
wm logo

Track and monitor all
your investments